In vivo data on the factors controlling angiotensin II (AII) cell surface binding are conflicting. We studied the specific effects of All on All binding in rat mesenteric artery vascular smooth muscle cells in culture. Incubation with unlabeled AII at 21°C resulted in time-and concentration-dependent decreases in All surface binding at 4°C, with a 30% reduction after exposure to 300 nM AII for 15 min. Reductions in cell surface binding were due to decrements in receptor number rather than changes in binding affinity. Loss of surface receptors was mediated by receptor internalization as maneuvers that blocked ligand internalization (cold temperature and phenylarsine oxide [PAOI) attenuated AII-induced loss of surface receptors. After removal of AII, recovery of surface binding was rapid (t1/2 = 15 min) and was mediated by reinsertion of a preexisting pool of receptors into the surface membrane rather than by new receptor synthesis. To determine the role of receptor cycling on AII-induced surface receptor loss, cells were incubated with the endosomal inhibitor chloroquine during exposure to AII at 21°C. Incubation with All plus chloroquine resulted in a 70% greater loss of surface binding than after incubation with AII alone. To determine the role of receptor cycling on uptake of ligand, cells were incubated with PAO or endosomal inhibitors during exposure to AII at 4 and 21°C. Compared with buffer these agents did not alter All uptake at 40C, but decreased uptake by 12-50% at 21°C. These results indicate that after binding All receptors cycle and that receptor cycling attenuates All-induced losses of surface receptors and enhances ligand uptake by providing a continuous source of receptors to the cell surface.
Introduction
Angiotensin II (AII)' is a potent vasoconstrictor hormone. Increased circulating concentrations ofAll have been implicated in the pathogenesis of some forms of hypertension and in the support of systemic vascular resistance during intravascular volume depletion. The cellular action of AII in vascular tissue is initiated by hormone binding to cell surface receptors. This hormone-receptor complex, possibly in association with a specific guanine nucleotide-binding protein (1, 2) , activates a phospholipase in the plasma membrane (3) . The subsequent hydrolysis of phosphatidyl inositol bisphosphate and phosphatidyl inositol results in the activation of inositol trisphosphate and diacylglycerol intracellular signals (4) (5) (6) (7) .
Although there is information on the postbinding cellular events mediating the action of AII, less is known about the fate of All and its surface receptor after binding. Translocation of All to the cell interior (internalization) has been described in the adrenal gland in vivo (8) , in cultured adrenocortical cells (9) , and in cultured vascular smooth muscle cells (10) . Little is known about the disposition of All receptors. In other hormone systems the fate of receptors varies after binding and ligand-receptor internalization. Once inside cells receptors may be degraded (e.g., epidermal growth factor) (11) , reinserted into the cell surface (e.g., LDL) (12) , or extruded from cells (e.g., transferrin during erythrocyte maturation) (13) . Moreover, either receptor redistribution or net loss of total receptor protein may occur in the same cell, depending on the duration of ligand exposure (e.g., insulin) (14) .
To date, most studies on the control ofvascular All surface receptors have been performed in membrane preparations of blood vessels from intact animals. The specific effects ofAII on All surface receptor availability and binding properties are difficult to ascertain from these studies because in addition to All other systemic factors appeared to alter the expression of All receptors. These modulating factors included potassium (15) , aldosterone (16) , and sex hormones (17) . Moreover, receptor trafficking cannot be assessed in isolated membranes because these preparations lack intracellular organs, such as endosomes, that contribute to intracellular receptor movement.
Our aims were to determine (a) the specific effect of changes in All concentration on the cellular distribution ofAII receptors in an isolated system, rat vascular smooth muscle cells in culture; and (b) the cellular pathways for AII receptor translocation after exposure to All.
Methods
Vascular smooth muscle cell isolation and maintenance. The techniques for mesentric artery vascular smooth muscle cell isolation and culture were modifications of those described by Ives et al. (18) and Gunther et al. ( 19) , and have been previously described in detail by us (20 control) (Fig. 5 A) . Similarly, preincubation with phenylarsine oxide attenuated unlabeled All-induced loss of surface '25I-AII binding (Fig. 5 B) . These results suggest that receptor internalization occurred rapidly and that receptor internalization mediated All-induced surface receptor loss, as maneuvers that prevented ligand internalization attenuated the loss of surface receptors after exposure to unlabeled AII.
We next studied recovery of '25I-AII surface binding after withdrawal of ligand. Cells were exposed to unlabeled All in After three saline washes cells were exposed to 300 nM unlabeled All or buffer at 21 'C for 30 min or at 4°C for 120 min, followed by acid washing and '25I-AII binding as described in Fig. 1 40 20 0.
1 concentrations (300 nM) sufficient to cause a 30% loss in cell surface binding. Fig. 6 A shows that recovery was rapid, with a t1/2 of 15 min at 21°C. The rapidity of recovery suggested that recovery occurred by translocation of existing receptors from the cell interior to the cell surface, rather than by the more time-consuming process of new receptor synthesis.
To further examine the role of reinsertion of existing receptors during recovery of surface binding, we determined the effect of protein synthesis inhibitors and agents that impair endosomal function on recovery of cell surface '25I-AII binding. In preliminary studies we determined that protein synthesis was inhibited by cycloheximide. Cells were incubated with or without cycloheximide (25 Ag/ml) for 30 min at 37°C. Cycloheximide blocked 13H]leucine incorporation into TCA-precipitable protein by 50±6% (n = 8). Fig. 6 B demonstrates that cycloheximide had no effect on the recovery of surface binding.
To determine whether recovery ofsurface binding required passage through an endosomal compartment, we used agents that purportedly increase endosomal pH: chloroquine, a diffusible weak base; and monensin, a carboxylic ionophore (29) . Exposure to either chloroquine or monensin blunted recovery of surface binding (Fig. 6 B) (P < 0.05 for each). These results suggest that receptor trafficking through endosomes is required for recovery after AII-induced loss of cell surface receptors.
Effect ofreceptor reinsertion on AII-induced loss ofsurface binding. Because the recovery of surface binding after removal of unlabeled AII appeared to be mediated by reinsertion of existing receptors, and because the time course of receptor internalization and recovery was rapid, we questioned whether concomitant receptor reinsertion could attenuate All-induced loss of surface binding. Cells were exposed to 0.2 mM chloroquine or buffer alone at 21°C for 60 min. After three saline washes both groups of cells were exposed to 300 nM unlabeled AII at 21°C for 30 min. Acid washing and "25I-AII binding at 4°C were performed as described in the legend of Fig. 1 . Preincubation with chloroquine accentuated reductions in cell surface binding induced by unlabeled AII by 73±4% (n = 5). These results suggest that translocation of receptors through endosomes back to the cell surface partially offsets surface receptor loss during exposure to unlabeled All.
Effect ofreceptor cycling on AII uptake. To further explore the consequences of rapid receptor cycling we examined the role of receptor cycling on ligand uptake. Cells were exposed to AII (tracer and unlabeled) at 4 or 21°C until steady-state uptake was reached (30 min at 21°C and 90 min at 4°C). Steady-state uptake of AII was increased twofold at 21°C compared with 4°C (Fig. 7) . To determine whether the increased uptake at 21°C was mediated by receptor cycling and continued uptake of ligand, uptake of tracer was examined in cells preincubated with agents that blocked internalization (phenylarsine oxide) or reinsertion (weak bases or monensin). '251I-AII uptake at 21°C was decreased after preincubation with each agent compared with preincubation with buffer (Fig. 8 A) . In contrast, '251I-AII uptake at 4°C was not reduced by any of these inhibitors (Fig. 8 B) . These data demonstrate that none of the inhibitors decrease ligand binding and that receptor cycling accounts for increased ligand uptake at 21 'C.
Discussion
The results of the present study demonstrate that after AII binding to vascular smooth muscle cells, ligand and receptors are internalized. After internalization receptors appear to move through an endosomal compartment and are reinserted into the cell surface. Receptor internalization mediates AII-induced reduction of cell surface binding. Reinsertion of receptors from the cell interior completely restores surface binding after All is removed and partially offsets losses of surface binding in the presence of AII. Finally, receptor cycling (internalization and reinsertion) enhances ligand uptake by vascular smooth muscle cells and accounts for increases in steady-state uptake at 21°C compared with 4°C.
The specific effects of All on the control of AII surface receptors and receptor trafficking are difficult to study in vivo. In addition to AII a number of other factors have been reported to alter AII surface binding. For example, potassium depletion (30) and mineralocorticoid excess (16) have been associated with increases in AII surface receptor number in smooth muscle cell membranes, while estrogens cause increases in receptor number in adrenal membranes (17) . Moreover, increases in AII concentration have been reported to both increase (31) and decrease (32) receptor density and decrease binding affinity (33) in smooth muscle cell membranes. In cultured vascular smooth muscle cells we found that All caused buffer-independent and time-, temperature-, and con- Incubation concentration of AII Figure 7 . Uptake of All by vascular smooth muscle cel tion of temperature at steady-state conditions. Cells we AII (tracer and unlabeled as described in Fig. 3 Few studies have addressed the role of receptor cycling (internalization and reinsertion) on ligand uptake. We found that steady-state All uptake was greater at 21°C, a temperature at which surface binding and cycling occur, than at 4°C, a temperature at which surface binding alone occurs. Since agents that impaired internalization or reinsertion of receptors markedly reduced ligand uptake at 21°C, the increased ligand uptake at 21°C was mediated by receptor trafficking. Since these agents did not affect uptake at 4°C, they did not affect surface binding.
The results of these studies may be important in interpreting binding data performed at different temperatures in intact cells (39, 40) . Steady-state uptake at 4°C represents true equilibrium surface binding (i.e., equal rates of ligand binding and ligand detachment from the receptor). In contrast, steady-state uptake at higher temperatures represents a pseudoequilibrium, presumably consisting of a complex interplay of surface binding, surface detachment, internalization, and reinsertion, as well as subsequent cycles ofbinding, internalization, and reinsertion. Under these conditions a steady state exists when the rate of association of radioactivity with cells equals the rate of extrusion of radioactivity from cells. Thus, binding analysis of studies performed at temperatures at which cycling occurs (e.g., 21°C) overestimates the apparent number of surface receptors. In contrast, binding studies at 4°C yield accurate estimates of surface receptor kinetics. For these reasons we did not calculate kinetic parameters of receptor binding from steadystate uptake studies performed at 21 'C.
Of interest was the observation that 251I-AII uptake was impaired to a greater extent by phenylarsine oxide than by the endosomal inhibitors. There are at least two possible explanations for these findings. Phenylarsine oxide prevents internalization, while endosomal inhibitors leave internalization intact. Thus, the cellular entry of ligand (radioactivity) occurs in the presence of endosomal inhibitors but not phenylarsine oxide. Also, since endosomal inhibitors are lysomorphic and thus impair ligand degradation in many systems (41), these agents may impair the cellular extrusion of radioactive ligand breakdown products.
Taken together, our studies suggest that receptor cycling could contribute to the control of AII action in vascular smooth muscle cells. By providing a continuous source of receptors to the cell surface, cycling enhances All uptake, internalization, and possibly second messenger formation. Along these lines, Griendling et al. have shown that sustained Allmediated diacylglycerol formation in vascular smooth muscle cells requires ligand-receptor internalization (10) . It is possible that cycled receptors may bind additional ligand, thereby providing additional ligand-receptor complexes for internalization and diacylglycerol formation. In addition, enhancing ligand uptake cycling would result in an efficient mechanism for AII degradation. Finally, by limiting AII-induced losses of surface receptor density during exposure to AII, receptor cycling could offset All-induced densensitization.
